Medicare AdvantageAdministrativeLow impact
MA11.049h, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
Independence Blue Cross·ENT (Ear, Nose & Throat)·Medical Policy
Effective date
May 27, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.049h regarding Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids has been reissued with an effective date of May 27, 2026. This appears to be a policy reissuance rather than substantive changes, but the specific policy details are not available in the summary provided.
Action Required
By May 27, 2026: Billing team should review the full policy document at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or billing procedures for bone-anchored hearing aids and implantable middle ear hearing devices for Medicare Advantage patients. Monitor for updated policy details as the effective date approaches.